UNSPSC 51343503: Tenofovir

This classification denotes a reverse transcriptase inhibitor and purine antagonist with the molecular formula C9H14N5O4P.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 99YXE507IL, chemically known as phosphonic acid, ((2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)-, (r)- but generally known as tenofovir, which bears US NIH Compound Identifier 464205. European Medicines Agency schedules Tenofovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04721MIG.

Most nations schedule tenofovir under HS 29335995 and SITC 51576. As of Q4 2014, TENOFOVIR remains the US FDA Preferred Term for this commodity. Tenofovir bears US NLM identifiers UMLS ID C0384228 and NCI Concept Code C29490. SMILES: P(=O)(O)(O)COC(Cn1c2ncnc(N)c2nc1)C.

UNSPSC 51343503 Tenofovir is a Commodity code for a specific antiretroviral pharmaceutical product, but recent state and local procurement activity tagged to this code shows minimal direct alignment with the product itself. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse cooperative to Chartwell Rx LLC on August 28, 2026, for supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets — antibiotics unrelated to Tenofovir — under an Invitation for Bid process. Seminole County, Florida posted an IFB on June 30, 2026, for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems, also outside the code's nominal scope. State and local purchasing offices appear to apply this Commodity code inconsistently or as a catch-all pharmaceutical tag, and the actual products being solicited under it diverge materially from Tenofovir itself.

The available record reflects two issuing bodies — a state health department and a county — with no repeat-buyer pattern evident. Illinois and Florida represent the geographic footprint in the recent-opportunities block. Opportunities are limited in the sample: the Illinois award is completed (not an open solicitation), and the Seminole County IFB carried a response deadline of July 26, 2023, making it substantially outdated. The mismatch between the code name and the products actually being bought suggests either inconsistent classification by procurement offices or opportunistic retagging of pharmaceutical RFQs and IFBs. Business development professionals pursuing state and local pharmaceutical supply should validate the actual product requirements in each RFP or IFB directly rather than relying on this Commodity code as a reliable market signal.